Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases

  • Fatemeh Zahedipour
  • , Paul C. Guest
  • , Muhammed Majeed
  • , Khalid Al-Rasadi
  • , Tannaz Jamialahmadi
  • , Amirhossein Sahebkar

Research output: Chapter in Book/Conference paperChapterpeer-review

Abstract

Statins have pleiotropic effects on inflammatory responses in addition to their lipid-lowering action, which contributes to their favorable effect on cardiovascular disorders. Statins affect adhesion, migration, antigen presentation, and cytokine generation of immune cells. Pre-clinical and clinical studies suggest that statin intervention targeted early in the infection might help COVID-19 patients to reduce the effects of acute respiratory distress syndrome (ARDS), the cytokine storm, and vascular collapse by modulating harmful pathogenic mechanisms. This chapter presents a protocol for measuring blood-based biomarkers predictive of these responses in COVID-19 patients using two specific multiplex immunoassays that target proteins that differ widely in concentration.
Original languageEnglish
Title of host publicationMethods in Molecular Biology
EditorsPaul Guest
PublisherHumana Press Inc.
Pages273-284
Number of pages12
DOIs
Publication statusPublished - 2022

Publication series

NameMethods in Molecular Biology
Volume2511
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases'. Together they form a unique fingerprint.

Cite this